Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…

SELB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 31.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Selecta Biosciences Insider Trading History Chart

Selecta Biosciences Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 11/14/2023 12:59 AM ET

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

Selecta Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/25/2023	Carsten Brunn	CEO	Sell	2,932	$1.06	$3,107.92	783,081
9/25/2023	Peter G. Traber	Insider	Sell	705	$1.06	$747.30	451,826
1/4/2023	Carsten Brunn	CEO	Sell	27,597	$1.13	$31,184.61	799,486
1/4/2023	Lloyd P Johnston	Insider	Sell	6,392	$1.13	$7,222.96	268,907
12/5/2022	Carsten Brunn	CEO	Sell	4,522	$1.33	$6,014.26	544,283
9/28/2022	Carsten Brunn	CEO	Sell	2,692	$1.66	$4,468.72	537,867
6/13/2022	Carrie Smith Cox	Director	Buy	130,000	$1.15	$149,500.00	212,881
5/9/2022	Timothy C Barabe	Director	Buy	50,000	$0.77	$38,500.00	250,013
1/5/2022	Carsten Brunn	CEO	Sell	13,597	$3.09	$42,014.73
1/5/2022	Peter G. Traber	Insider	Sell	3,226	$3.09	$9,968.34

Most People Are Dead Wrong.

From Brownstone Research | Ad

Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

SEC Filings (Institutional Ownership Changes) for Selecta Biosciences (NASDAQ:SELB)

41.95% of Selecta Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Selecta Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/13/2023	Personal CFO Solutions LLC	54,888	$58K	0.0%	-35.3%	0.035%
11/7/2023	New York State Common Retirement Fund	45,266	$48K	0.0%	-46.6%	0.029%
10/27/2023	Allspring Global Investments Holdings LLC	47,895	$51K	0.0%	N/A	0.031%
10/24/2023	Bank of New York Mellon Corp	590,984	$0.63M	0.0%	+1.9%	0.385%
10/13/2023	SG Americas Securities LLC	41,938	$44K	0.0%	N/A	0.027%
9/21/2023	Barclays PLC	61,240	$69K	0.0%	+61.2%	0.040%
8/15/2023	Sphera Funds Management LTD.	2,038,500	$2.28M	0.4%	-12.3%	1.329%
8/11/2023	Artal Group S.A.	9,136,635	$10.23M	0.3%	+87.1%	5.955%
8/4/2023	American International Group Inc.	55,902	$63K	0.0%	N/A	0.036%
8/4/2023	CM Management LLC	700,000	$0.78M	0.8%	+16.7%	0.456%
8/3/2023	Mackenzie Financial Corp	27,689	$31K	0.0%	+74.2%	0.018%
7/27/2023	Virtu Financial LLC	55,759	$62K	0.0%	N/A	0.036%
5/15/2023	EcoR1 Capital LLC	200,000	$0.28M	0.0%	-94.3%	0.130%
5/12/2023	Mirabella Financial Services LLP	145,423	$4.03M	0.6%	+317.0%	0.095%
5/11/2023	Acadian Asset Management LLC	1,509,229	$2.10M	0.0%	-9.6%	0.984%
5/3/2023	Jump Financial LLC	91,600	$0.13M	0.0%	N/A	0.060%
4/27/2023	Simplex Trading LLC	35,158	$48K	0.0%	N/A	0.023%
4/26/2023	James Investment Research Inc.	35,520	$49K	0.0%	N/A	0.023%
2/15/2023	Endurant Capital Management LP	3,777,618	$4.27M	1.7%	-4.1%	2.469%
2/13/2023	GSA Capital Partners LLP	372,087	$0.42M	0.1%	-48.7%	0.243%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	27,239	$31K	0.0%	-81.5%	0.018%
2/9/2023	Citigroup Inc.	303,660	$0.34M	0.0%	+2,090.3%	0.198%
2/1/2023	Bank of Montreal Can	232,300	$0.26M	0.0%	-78.0%	0.152%
1/31/2023	Ironwood Investment Management LLC	177,182	$0.20M	0.1%	-11.0%	0.116%
11/15/2022	Mangrove Partners	5,260,419	$8.63M	0.5%	-27.5%	3.438%
11/15/2022	Endurant Capital Management LP	3,938,409	$6.46M	2.1%	-14.6%	2.574%
11/15/2022	BVF Inc. IL	1,391,749	$2.28M	0.1%	-19.2%	0.909%
11/15/2022	Bayesian Capital Management LP	44,274	$73K	0.0%	N/A	0.029%
11/15/2022	Caxton Associates LP	97,193	$0.16M	0.0%	N/A	0.064%
11/14/2022	Lazard Asset Management LLC	48,365	$79K	0.0%	N/A	0.032%
11/14/2022	Healthcare of Ontario Pension Plan Trust Fund	720,800	$1.18M	0.0%	N/A	0.471%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	146,850	$0.24M	0.0%	-7.6%	0.096%
11/10/2022	Bank of Montreal Can	1,054,700	$2.30M	0.0%	N/A	0.689%
11/9/2022	NanoDimension Inc.	3,787,515	$6.21M	25.2%	-5.4%	2.475%
11/8/2022	IFP Advisors Inc	47,110	$0.57M	0.0%	+49.3%	0.031%
11/7/2022	Virtu Financial LLC	22,925	$38K	0.0%	N/A	0.015%
11/4/2022	Russell Investments Group Ltd.	46,856	$76K	0.0%	-15.7%	0.031%
11/1/2022	Personal CFO Solutions LLC	85,888	$0.14M	0.0%	+21.2%	0.056%
8/11/2022	Artal Group S.A.	4,883,200	$6.40M	0.3%	+22.1%	3.217%
8/8/2022	CM Management LLC	600,000	$0.79M	0.8%	+20.0%	0.395%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	158,891	$0.21M	0.0%	-55.1%	0.105%
7/29/2022	Russell Investments Group Ltd.	55,557	$72K	0.0%	-20.0%	0.037%
7/28/2022	NanoDimension Inc.	4,002,515	$5.24M	17.2%	+9.7%	2.637%
7/27/2022	Bailard Inc.	50,000	$66K	0.0%	N/A	0.033%
7/13/2022	Private Advisor Group LLC	35,200	$46K	0.0%	N/A	0.023%
5/17/2022	Endurant Capital Management LP	3,451,958	$4.25M	1.1%	+62.6%	2.274%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	353,760	$0.44M	0.0%	-18.2%	0.233%
5/11/2022	GSA Capital Partners LLP	151,493	$0.19M	0.0%	N/A	0.100%
5/9/2022	CM Management LLC	500,000	$0.62M	0.5%	+25.0%	0.329%
5/6/2022	Los Angeles Capital Management LLC	198,955	$0.25M	0.0%	-6.0%	0.131%
5/5/2022	Russell Investments Group Ltd.	69,420	$84K	0.0%	-42.4%	0.046%
5/2/2022	Personal CFO Solutions LLC	74,888	$92K	0.0%	+35.2%	0.049%
4/29/2022	SG Americas Securities LLC	67,377	$83K	0.0%	+86.4%	0.044%
2/23/2022	NanoDimension Inc.	3,647,907	$11.89M	10.7%	N/A	3.127%
2/14/2022	Virtus ETF Advisers LLC	52,145	$0.17M	0.1%	+22.9%	0.045%
2/14/2022	Blair William & Co. IL	14,950	$49K	0.0%	N/A	0.013%
2/10/2022	Qube Research & Technologies Ltd	66,154	$0.22M	0.0%	N/A	0.057%
2/10/2022	Rafferty Asset Management LLC	14,346	$47K	0.0%	-90.8%	0.012%
2/10/2022	Acadian Asset Management LLC	572,806	$1.87M	0.0%	-30.1%	0.491%
2/9/2022	Principal Financial Group Inc.	70,741	$0.23M	0.0%	-55.3%	0.061%
2/9/2022	BNP Paribas Arbitrage SA	341,824	$1.11M	0.0%	+1,386.1%	0.293%
2/9/2022	Lazard Asset Management LLC	18,568	$60K	0.0%	+46.8%	0.016%
2/8/2022	Northern Trust Corp	825,000	$2.69M	0.0%	-2.4%	0.707%
2/7/2022	SG Americas Securities LLC	36,137	$0.12M	0.0%	-91.6%	0.031%
2/4/2022	IndexIQ Advisors LLC	93,327	$0.30M	0.0%	-6.1%	0.080%
2/3/2022	Los Angeles Capital Management LLC	211,612	$0.69M	0.0%	+1,035.4%	0.181%
2/3/2022	OUP Management Co. LLC	862,543	$2.81M	1.3%	N/A	0.739%
2/1/2022	Qube Research & Technologies Ltd	66,154	$0.22M	0.0%	N/A	0.057%
1/28/2022	Allspring Global Investments Holdings LLC	140,045	$0.46M	0.0%	N/A	0.120%
1/21/2022	Russell Investments Group Ltd.	120,450	$0.39M	0.0%	-38.9%	0.103%
11/18/2021	Personal CFO Solutions LLC	43,339	$0.18M	0.0%	+49.0%	0.037%
11/16/2021	Opaleye Management Inc.	106,000	$0.44M	0.1%	N/A	0.091%
11/16/2021	Two Sigma Advisers LP	1,514,100	$6.30M	0.0%	-8.3%	1.298%
11/16/2021	Two Sigma Investments LP	1,250,224	$5.20M	0.0%	-24.5%	1.072%
11/16/2021	Metropolitan Life Insurance Co NY	11,740	$49K	0.0%	-55.9%	0.010%
11/16/2021	BVF Inc. IL	319,678	$1.33M	0.1%	-81.1%	0.274%
11/16/2021	Beacon Pointe Advisors LLC	19,000	$79K	0.0%	N/A	0.016%
11/15/2021	Man Group plc	179,391	$0.75M	0.0%	+15.4%	0.154%
11/15/2021	HighVista Strategies LLC	22,269	$92K	0.1%	N/A	0.019%
11/15/2021	Franklin Resources Inc.	90,700	$0.38M	0.0%	N/A	0.078%
11/15/2021	Natixis	11,300	$47K	0.0%	N/A	0.010%
11/12/2021	Renaissance Technologies LLC	262,200	$1.09M	0.0%	-38.8%	0.228%
11/12/2021	Capital Fund Management S.A.	63,176	$0.26M	0.0%	N/A	0.055%
11/12/2021	The Manufacturers Life Insurance Company	50,100	$0.21M	0.0%	-6.3%	0.044%
11/12/2021	Arrowstreet Capital Limited Partnership	185,839	$0.77M	0.0%	N/A	0.161%
11/12/2021	Geode Capital Management LLC	1,731,281	$7.20M	0.0%	+6.7%	1.504%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	430,052	$1.79M	0.0%	+94.4%	0.374%
11/10/2021	Goldman Sachs Group Inc.	1,296,338	$5.39M	0.0%	-19.7%	1.126%
11/10/2021	IndexIQ Advisors LLC	99,359	$0.41M	0.0%	+11.1%	0.086%
11/10/2021	Citigroup Inc.	112,509	$0.47M	0.0%	+844.3%	0.098%
11/10/2021	Rafferty Asset Management LLC	155,326	$0.65M	0.0%	N/A	0.135%
11/10/2021	Healthcare of Ontario Pension Plan Trust Fund	508,700	$2.12M	0.0%	N/A	0.442%
11/9/2021	Barclays PLC	37,112	$0.16M	0.0%	+27.6%	0.032%
11/9/2021	BlackRock Inc.	6,965,596	$28.98M	0.0%	+4.1%	6.053%
11/9/2021	WNY Asset Management LLC	11,800	$49K	0.0%	N/A	0.010%
11/9/2021	Principal Financial Group Inc.	158,355	$0.66M	0.0%	-8.8%	0.138%
11/8/2021	Russell Investments Group Ltd.	197,012	$0.82M	0.0%	-31.6%	0.171%
11/8/2021	Los Angeles Capital Management LLC	18,637	$78K	0.0%	+72.9%	0.016%
11/4/2021	Deutsche Bank AG	599,739	$2.50M	0.0%	-10.0%	0.521%
11/2/2021	New York State Common Retirement Fund	51,899	$0.22M	0.0%	-32.7%	0.045%

Data available starting January 2016

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in Phase I clinical trial to enhance the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat autoimmune diseases. The company has license and collaboration agreements with Ginkgo Bioworks Holdings, Inc.; Genovis AB (publ.); Cyrus Biotechnology, Inc.; IGAN Biosciences, Inc.; Astellas Therapeutics, Inc.; Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum AB (publ.); Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; and Shenyang Sunshine Pharmaceutical Co., Ltd. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: N/A

50 Day Range

MA: $1.06

$0.88

$1.26

52 Week Range

Now: N/A

Volume

2,774,100 shs

Average Volume

979,585 shs

Market Capitalization

$136.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Selecta Biosciences?: Selecta Biosciences' top insider investors include:
Carsten Brunn (CEO)
Peter G Traber (Insider)
Lloyd P Johnston (Insider)
Learn More about top insider investors at Selecta Biosciences.